Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Protein 4.1B suppresses prostate cancer progression and metastasis.

Wong SY, Haack H, Kissil JL, Barry M, Bronson RT, Shen SS, Whittaker CA, Crowley D, Hynes RO.

Proc Natl Acad Sci U S A. 2007 Jul 31;104(31):12784-9. Epub 2007 Jul 18.

2.

Raf kinase inhibitor protein (RKIP) deficiency decreases latency of tumorigenesis and increases metastasis in a murine genetic model of prostate cancer.

Escara-Wilke J, Keller JM, Ignatoski KM, Dai J, Shelley G, Mizokami A, Zhang J, Yeung ML, Yeung KC, Keller ET.

Prostate. 2015 Feb 15;75(3):292-302. doi: 10.1002/pros.22915. Epub 2014 Oct 18.

3.

Increased expression of delta-catenin/neural plakophilin-related armadillo protein is associated with the down-regulation and redistribution of E-cadherin and p120ctn in human prostate cancer.

Lu Q, Dobbs LJ, Gregory CW, Lanford GW, Revelo MP, Shappell S, Chen YH.

Hum Pathol. 2005 Oct;36(10):1037-48. Epub 2005 Sep 6.

PMID:
16226102
4.

Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis.

Saini S, Majid S, Yamamura S, Tabatabai L, Suh SO, Shahryari V, Chen Y, Deng G, Tanaka Y, Dahiya R.

Clin Cancer Res. 2011 Aug 15;17(16):5287-98. doi: 10.1158/1078-0432.CCR-10-2619. Epub 2010 Dec 15.

5.

The Drg-1 gene suppresses tumor metastasis in prostate cancer.

Bandyopadhyay S, Pai SK, Gross SC, Hirota S, Hosobe S, Miura K, Saito K, Commes T, Hayashi S, Watabe M, Watabe K.

Cancer Res. 2003 Apr 15;63(8):1731-6.

6.

Expression and role of Foxa proteins in prostate cancer.

Mirosevich J, Gao N, Gupta A, Shappell SB, Jove R, Matusik RJ.

Prostate. 2006 Jul 1;66(10):1013-28.

PMID:
16001449
8.

Aberrant expression of tumor suppressors CADM1 and 4.1B in invasive lesions of primary breast cancer.

Takahashi Y, Iwai M, Kawai T, Arakawa A, Ito T, Sakurai-Yageta M, Ito A, Goto A, Saito M, Kasumi F, Murakami Y.

Breast Cancer. 2012 Jul;19(3):242-52. doi: 10.1007/s12282-011-0272-7. Epub 2011 Apr 28.

PMID:
21526423
9.

Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter.

Spitzweg C, O'Connor MK, Bergert ER, Tindall DJ, Young CY, Morris JC.

Cancer Res. 2000 Nov 15;60(22):6526-30.

10.

Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma.

Cordon-Cardo C, Koff A, Drobnjak M, Capodieci P, Osman I, Millard SS, Gaudin PB, Fazzari M, Zhang ZF, Massague J, Scher HI.

J Natl Cancer Inst. 1998 Sep 2;90(17):1284-91.

PMID:
9731735
11.

Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss.

Dong JT, Suzuki H, Pin SS, Bova GS, Schalken JA, Isaacs WB, Barrett JC, Isaacs JT.

Cancer Res. 1996 Oct 1;56(19):4387-90.

12.

The tumor metastasis suppressor gene Drg-1 down-regulates the expression of activating transcription factor 3 in prostate cancer.

Bandyopadhyay S, Wang Y, Zhan R, Pai SK, Watabe M, Iiizumi M, Furuta E, Mohinta S, Liu W, Hirota S, Hosobe S, Tsukada T, Miura K, Takano Y, Saito K, Commes T, Piquemal D, Hai T, Watabe K.

Cancer Res. 2006 Dec 15;66(24):11983-90.

13.
14.

ADAM15 supports prostate cancer metastasis by modulating tumor cell-endothelial cell interaction.

Najy AJ, Day KC, Day ML.

Cancer Res. 2008 Feb 15;68(4):1092-9. doi: 10.1158/0008-5472.CAN-07-2432.

15.

Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion.

Williams TM, Medina F, Badano I, Hazan RB, Hutchinson J, Muller WJ, Chopra NG, Scherer PE, Pestell RG, Lisanti MP.

J Biol Chem. 2004 Dec 3;279(49):51630-46. Epub 2004 Sep 7.

16.
17.

3,3'-Diindolylmethane enhances taxotere-induced apoptosis in hormone-refractory prostate cancer cells through survivin down-regulation.

Rahman KM, Banerjee S, Ali S, Ahmad A, Wang Z, Kong D, Sakr WA.

Cancer Res. 2009 May 15;69(10):4468-75. doi: 10.1158/0008-5472.CAN-08-4423. Epub 2009 May 12.

18.

Organ specific Gst-pi expression of the metastatic androgen independent prostate cancer cells in nude mice.

Naiki T, Asamoto M, Toyoda-Hokaiwado N, Naiki-Ito A, Tozawa K, Kohri K, Takahashi S, Shirai T.

Prostate. 2012 Apr;72(5):533-41. doi: 10.1002/pros.21455. Epub 2011 Jul 11.

PMID:
21748757
19.

The 4.1/ezrin/radixin/moesin domain of the DAL-1/Protein 4.1B tumour suppressor interacts with 14-3-3 proteins.

Yu T, Robb VA, Singh V, Gutmann DH, Newsham IF.

Biochem J. 2002 Aug 1;365(Pt 3):783-9.

20.

Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice.

Pettaway CA, Pathak S, Greene G, Ramirez E, Wilson MR, Killion JJ, Fidler IJ.

Clin Cancer Res. 1996 Sep;2(9):1627-36.

Supplemental Content

Support Center